Vincent S Chan

USPTO Granted Patents = 16 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 10)

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 56(Granted Patents)

Company Filing History:

4. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2014-2019

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10174061 - Carbidopa and L-dopa prodrugs and methods of use (2019-01-08),

2. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein (2018-11-06),

3. 9732045 - Process for preparing antiviral compounds (2017-08-15),

4. 9669399 - Phosphine ligands for catalytic reactions (2017-06-06),

5. 9446059 - Carbidopa and L-dopa prodrugs and methods of use (2016-09-20),

6. 9434698 - Process for preparing antiviral compounds (2016-09-06),

7. 9381508 - Phosphine ligands for catalytic reactions (2016-07-05),

8. 9266913 - Phosphine ligands for catalytic reactions (2016-02-23),

9. 9255074 - Process for preparing antiviral compounds (2016-02-09),

10. 9238652 - Processes for the preparation of an apoptosis-inducing agent (2016-01-19),

11. 9200021 - Phosphine ligands for catalytic reactions (2015-12-01),

12. 9199992 - Processes for the preparation of an apoptosis-inducing agent (2015-12-01),

13. 9006438 - Processes for the preparation of an apoptosis-inducing agent (2015-04-14),

14. 8975443 - Phosphine ligands for catalytic reactions (2015-03-10),

15. 8895737 - Process for preparing antiviral compounds (2014-11-25),

Title: Innovator Spotlight: Vincent S. Chan

Introduction

Vincent S. Chan is a prominent inventor based in Evanston, IL, recognized for his significant contributions to pharmaceutical innovations. With a notable portfolio consisting of 16 patents, Chan has dedicated his career to developing advanced treatments for various medical conditions, particularly those affecting neurological and respiratory health.

Latest Patents

Among Chan's latest patents are groundbreaking developments in the treatment of Parkinson's disease. His work on carbidopa and L-dopa prodrugs outlines pharmaceutical combinations and compositions that enhance therapeutic outcomes for patients struggling with this condition. Additionally, he has invented modulators for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. These compounds are designed to treat diseases like cystic fibrosis, Sjögren's syndrome, and chronic obstructive lung disease, showcasing his commitment to advancing medical science through innovative solutions.

Career Highlights

Vincent S. Chan has been affiliated with leading pharmaceutical organizations such as AbbVie Inc. and AbbVie S.à.r.l. His experience in these companies underscores his expertise in drug development and his role in pioneering life-altering treatments through his inventions.

Collaborations

Throughout his career, Chan has collaborated with talented individuals such as Shashank Shekhar and Thaddeus Stephan Franczyk II. These partnerships have fostered an environment of innovation, propelling the development of cutting-edge therapies and enhancing the scientific community's knowledge.

Conclusion

Vincent S. Chan exemplifies the spirit of innovation through his extensive work in the field of pharmaceuticals. His 16 patents not only highlight his dedication to improving human health but also reflect the dynamic interplay between research and application. As he continues to contribute to the medical field, Chan's legacy as an inventor will undoubtedly influence future generations.

This text is generated by artificial intelligence and may not be accurate.